Published in Pediatr Nephrol on January 10, 2007
A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index. Pediatr Nephrol (2008) 0.92
Correspondence between Ca²⁺ and calciuria, citrate level and pH of urine in pediatric urolithiasis. Pediatr Nephrol (2013) 0.80
Relevance of the BONN Risk Index for metabolic monitoring of patients with calcium oxalate urolithiasis: a clinical application study of the Urolizer. Urol Res (2009) 0.79
Urinary citrate excretion in healthy children depends on age and gender. Pediatr Nephrol (2014) 0.75
Evaluation of pediatric nephrolithiasis. Indian J Urol (2010) 0.75
Kinetics of calcium oxalate crystal formation in urine. Urolithiasis (2016) 0.75
Spontaneous urinary calcium oxalate crystallization in hypercalciuric children. Pediatr Nephrol (2009) 0.75
Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int (2003) 9.11
EQUIL2: a BASIC computer program for the calculation of urinary saturation. J Urol (1985) 2.71
Urinary excretion of acid mucopolysaccharides in normal children and patients with gargoylism. J Lab Clin Med (1962) 1.44
Nephrocalcinosis: molecular insights into calcium precipitation within the kidney. Clin Sci (Lond) (2004) 1.33
Hyperoxaluric calcium nephrolithiasis. Endocrinol Metab Clin North Am (2002) 1.21
When is medical prophylaxis cost-effective for recurrent calcium stones? J Urol (2002) 1.16
Nephrolithiasis in children. Pediatr Nephrol (2005) 1.12
Risk formulas in calcium oxalate urolithiasis. World J Urol (1997) 1.11
A new approach to calculate the risk of calcium oxalate crystallization from unprepared native urine. Urol Res (2000) 1.07
Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria. Front Biosci (2003) 1.02
Role of urinary supersaturation in the evaluation of children with urolithiasis. Pediatr Nephrol (2005) 0.97
Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients. J Urol (2002) 0.96
Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls? J Urol (2006) 0.94
Urinary calcium oxalate saturation in healthy infants and children. J Urol (1997) 0.92
Clinical implications of physicochemistry of stone formation. Endocrinol Metab Clin North Am (2002) 0.86
Oxalate and its handling in a low stone risk vs a stone-prone population group. World J Urol (2005) 0.85
Can the Bonn Risk Index be replaced by a simple measurement of the urinary concentration of free calcium ions? J Urol (2005) 0.82
Comparison of laser-probe and photometric determination of the urinary crystallization risk of calcium oxalate. Clin Chem Lab Med (2002) 0.82
Renal calculi in children: imaging features that lead to diagnoses: a pictorial essay. Pediatr Radiol (1999) 0.78
Levels of urinary inter-alpha-trypsin inhibitor trimer as a function of age and sex-hormone status in males and females not forming stones. BJU Int (2002) 0.78
Hematological parameters in adolescents with hyperuricemia. Indian Pediatr (2014) 2.00
Assessment of lithogenic risk in children based on a morning spot urine sample. J Urol (2010) 1.45
Polish 2010 growth references for school-aged children and adolescents. Eur J Pediatr (2010) 1.40
Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol (2013) 1.25
KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatr Nephrol (2011) 1.23
Genetic screening in adolescents with steroid-resistant nephrotic syndrome. Kidney Int (2013) 1.21
Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity? Pediatr Nephrol (2010) 1.11
Patients' perceptions of GP non-verbal communication: a qualitative study. Br J Gen Pract (2010) 1.07
Perception of health-related quality of life in children with chronic kidney disease by the patients and their caregivers: multicentre national study results. Qual Life Res (2013) 0.94
A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index. Pediatr Nephrol (2008) 0.92
Hypertension in dialysed children: the prevalence and therapeutic approach in Poland--a nationwide survey. Nephrol Dial Transplant (2005) 0.91
MDR-1 gene polymorphisms and clinical course of steroid-responsive nephrotic syndrome in children. Pediatr Nephrol (2006) 0.90
The patient's view of the acceptability of the primary care in Poland. Int J Qual Health Care (2008) 0.88
Perivascular epithelioid tumor (PEComa) of the falciform/ broad ligament. Pol J Pathol (2008) 0.87
Effect of cyclosporin A on proteinuria in the course of glomerulopathy associated with WT1 mutations. Eur J Pediatr (2010) 0.86
Does obesity or hyperuricemia influence lithogenic risk profile in children with urolithiasis? Pediatr Nephrol (2014) 0.86
Involvement of family nurses in home visits during an 8-year period encompassing primary healthcare reforms in Poland. Health Soc Care Community (2008) 0.85
Urinary cytokine profiles in unilateral congenital hydronephrosis. Pediatr Nephrol (2012) 0.84
Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome. Pediatr Nephrol (2014) 0.83
Urinary angiotensinogen as a marker of intrarenal angiotensin II activity in adolescents with primary hypertension. Pediatr Nephrol (2013) 0.81
Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria. Scand J Urol Nephrol (2010) 0.81
Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children. Pediatr Nephrol (2010) 0.81
Response to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndrome. Pediatr Nephrol (2008) 0.81
Evaluation of bladder instability in children with recurrent urinary tract infections. Med Sci Monit (2002) 0.81
Assessment of serum cystatin C in children with congenital solitary kidney. Pediatr Nephrol (2006) 0.81
Urinary angiotensinogen as a novel marker of obstructive nephropathy in children. Acta Paediatr (2013) 0.80
Little evidence of low bone mass in acute lymphoblastic leukemia survivors. J Clin Densitom (2011) 0.80
A potential pathogenic role of oxalate in autism. Eur J Paediatr Neurol (2011) 0.80
Expression of glucocorticoid receptors in mononuclear cells in nephrotic syndrome. Pediatr Nephrol (2003) 0.80
Correspondence between Ca²⁺ and calciuria, citrate level and pH of urine in pediatric urolithiasis. Pediatr Nephrol (2013) 0.80
Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy. Pediatr Nephrol (2014) 0.79
Subclinical cardiovascular system changes in obese patients with juvenile idiopathic arthritis. Mediators Inflamm (2013) 0.79
Expression of P-glycoprotein in lymphocytes from children with nephrotic syndrome, depending on their steroid response. Pediatr Nephrol (2006) 0.79
Functional bladder capacity and urine osmolality in children with primary monosymptomatic nocturnal enuresis. Scand J Urol Nephrol (2005) 0.79
Osteopontin and symmetric dimethylarginine plasma levels in solitary functioning kidney in children. Acta Paediatr (2012) 0.79
Epidemiological study of acute poisoning in children: a 5-year retrospective study in the Paediatric University Hospital in Białystok, Poland. Emerg Med J (2012) 0.79
[Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia]. Pol Merkur Lekarski (2007) 0.79
Paediatric normative data for urine NGAL/creatinine ratio. Acta Paediatr (2013) 0.78
Psychosocial aspects of children and families of children treated with automated peritoneal dialysis. Pediatr Nephrol (2013) 0.78
Is plasma symmetric dimethylarginine a suitable marker of renal function in children and adolescents? Scand J Urol Nephrol (2011) 0.78
Glucocorticoid receptor and vascular endothelial growth factor in nephrotic syndrome. Acta Paediatr (2006) 0.78
Comparison of phalangeal ultrasound and dual energy X-ray absorptiometry in healthy male and female adolescents. Ultrasound Med Biol (2005) 0.78
Mutational analysis in podocin-associated hereditary nephrotic syndrome in Polish patients: founder effect in the Kashubian population. J Appl Genet (2013) 0.78
A need to establish normative data for plasma oxalates. Am J Kidney Dis (2008) 0.78
Reference values of plasma oxalate in children and adolescents. Pediatr Nephrol (2008) 0.78
Body composition and bone mass in survivors of childhood cancer. Pediatr Blood Cancer (2007) 0.78
[Bone mineral density in children before and after completion of cancer treatment]. Pol Merkur Lekarski (2004) 0.77
Serum 25-hydroxyvitamin D, osteocalcin, and parathormone status in children with meningomyelocele. Neuropediatrics (2012) 0.77
Serum copeptin levels in adolescents with primary hypertension. Pediatr Nephrol (2013) 0.77
[Serum and urinary homocysteine in children with steroid-dependent nephrotic syndrome]. Pol Merkur Lekarski (2011) 0.77
[WT1 mutation as a cause of progressive nephropathy in Frasier syndrome--case report]. Pol Merkur Lekarski (2009) 0.77
Urinary nerve growth factor level in children with neurogenic bladder due to myelomeningocele. Scand J Urol (2013) 0.77
Urine NGAL and KIM-1 in children and adolescents with hyperuricemia. Pediatr Nephrol (2013) 0.77
Urinary transforming growth factor beta1 in children and adolescents with congenital solitary kidney. Pediatr Nephrol (2008) 0.76
[Chronic peritoneal dialysis in infants--preliminary results of the multicenter survey]. Przegl Lek (2006) 0.76
Urine fibroblast growth factor 23 levels in hypertensive children and adolescents. Croat Med J (2015) 0.76
[FGF23 and Klotho protein--the role in the pathogenesis of hypertension]. Wiad Lek (2015) 0.76
Is symmetric dimethylarginine a sensitive biomarker of subclinical kidney injury in children born with low birth weight? Biomarkers (2014) 0.76
Does Q223R Polymorphism of Leptin Receptor Influence on Anthropometric Parameters and Bone Density in Childhood Cancer Survivors? Int J Endocrinol (2013) 0.76
Is the treatment for childhood solid tumors associated with lower bone mass than that for leukemia and Hodgkin disease? Pediatr Hematol Oncol (2009) 0.76
Laminin and transforming growth factor beta-1 in children with vesicoureteric reflux. Pediatr Nephrol (2008) 0.76
High-sensitivity C-reactive protein (hs-CRP) level in children with nephrotic syndrome. Pediatr Nephrol (2006) 0.75
Expression of glucocorticoid receptors in nephrotic children depending on total prednisone dose. J Pediatr Endocrinol Metab (2005) 0.75
Serum and urine leptin concentration in children with nephrotic syndrome. Pediatr Nephrol (2005) 0.75
Serum matrix metalloproteinase-9 levels and severity of symptoms in boys with attention deficit hyperactivity disorder ADHD/hyperkinetic disorder HKD. Eur Child Adolesc Psychiatry (2014) 0.75
Evaluation of Serum Uric Acid: Authors' Reply. Indian Pediatr (2015) 0.75
New insight into the role of patients during medical appointments: a synthesis of three qualitative studies. Patient (2014) 0.75
Urinary citrate excretion in healthy children depends on age and gender. Pediatr Nephrol (2014) 0.75
Some remarks on self-reported and measured height and weight in adolescents. J Adolesc Health (2006) 0.75
The effects of breastfeeding on serum asymmetric dimethylarginine levels and body composition in children. Breastfeed Med (2014) 0.75
Is the serum level of salusin-β associated with hypertension and atherosclerosis in the pediatric population? Pediatr Nephrol (2014) 0.75
Low milk consumption in childhood and fragility fractures. Comment on an article by Monti et al. Ann Nutr Metab (2008) 0.75
Urinary MMP-9/NGAL ratio as a potential marker of FSGS in nephrotic children. Dis Markers (2013) 0.75
Normal values for urine renalase excretion in children. Pediatr Nephrol (2014) 0.75
New tubular injury markers in children with a solitary functioning kidney. Pediatr Nephrol (2014) 0.75
Anxiety in children and adolescents with chronic kidney disease--multicenter national study results. Kidney Blood Press Res (2013) 0.75
Asymmetric and symmetric dimethylarginine in adolescents with hyperuricemia. Dis Markers (2013) 0.75
[Vertebral compression fractures--the first manifestations of acute lymphoblastic leukemia of childhood]. Med Wieku Rozwoj (2005) 0.75
Expression of multidrug resistance P-glycoprotein on lymphocytes from nephrotic children treated with cyclosporine A and ACE-inhibitor. Eur J Pediatr (2006) 0.75
Spontaneous urinary calcium oxalate crystallization in hypercalciuric children. Pediatr Nephrol (2009) 0.75
[Bone mineral density in children and adolescents with idiopathic chronic musculoskeletal pain syndromes]. Pol Merkur Lekarski (2006) 0.75
Vascular endothelial growth factor in children with nephrotic syndrome treated with cyclosporine A. Acta Paediatr (2006) 0.75
[Relationship between bone mineral content and growth disorders in children with juvenile idiopathic arthritis]. Pol Merkur Lekarski (2008) 0.75
[The concentration of plasma anion oxalate in children treatment antibiotics beta lactame]. Pol Merkur Lekarski (2006) 0.75
[Analysis of vesicoureteral reflux (VUR) course in children]. Pol Merkur Lekarski (2008) 0.75
Serum and urine fibronectin levels in children with vesicoureteral reflux. Pediatr Nephrol (2007) 0.75
[Urinary laminin and fibronectin level in children with nephritic syndrome]. Pol Merkur Lekarski (2009) 0.75
[Effect of anticancer treatment on leptin level, fat body mass (FM) and lean body mass (LBM)]. Med Wieku Rozwoj (2005) 0.75
[The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children]. Pol Merkur Lekarski (2005) 0.75